Phibro Animal Health PAHC Business Segments
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Animal Health | $291.23M+12.7% | $289.98M+26.4% | $283.46M+55.3% | $292.48M+52.7% | $258.38M+42.5% | |
| Mineral Nutrition | $73.42M+9.9% | $68.95M+9.0% | $62.99M+6.6% | $64.15M+3.4% | $66.77M+4.0% | |
| Performance Products | $18.9M-16.6% | $14.99M-9.7% | $17.45M-7.4% | $22.07M+12.7% | $22.67M+28.4% | |
| Selling General And Administrative Expense by Business | ||||||
| Mineral Nutrition | $1.99M+0.7% | $1.9M+11.5% | $1.72M-11.1% | $2.03M+11.6% | $1.97M+8.5% | |
| Performance Products | $2.24M+5.3% | $2.39M+16.7% | $2.12M+2.1% | $2.16M+7.4% | $2.12M+5.7% | |
| Adjusted Earnings Before Interest Taxes Depreciation And Amortization by Business | ||||||
| Mineral Nutrition | $5.14M-10.8% | $6.37M+11.7% | $4.52M+20.2% | $5.61M+4.0% | $5.76M+23.5% | |
| Performance Products | $2.22M-33.5% | $831K-56.0% | $1.6M-29.9% | $3.03M-1.0% | $3.34M+40.7% | |
| Cost of Goods Sold by Business | ||||||
| Mineral Nutrition | $66.84M+12.2% | $61.22M+8.6% | $57.28M+6.3% | $57.06M+2.6% | $59.56M+7.1% | |
| Performance Products | $14.69M-16.0% | $12.01M-7.3% | $13.95M-5.8% | $17.11M+27.8% | $17.49M+30.7% | |
| D&A by Business | ||||||
| Mineral Nutrition | $548K+4.6% | $541K+5.0% | $534K+3.5% | $547K+5.2% | $524K-12.8% | |
| Performance Products | $249K-10.1% | $241K-17.5% | $226K-32.1% | $235K-40.8% | $277K-35.9% | |
| Revenue by Product | ||||||
| Medicated Feed Additives And Others | $205.79M+13.3% | $202.11M+34.4% | $195.2M+81.0% | $206.53M+77.0% | $181.65M+67.9% | |
| Mineral Nutrition | $73.42M+9.9% | $68.95M+9.0% | $62.99M+6.6% | $64.15M+3.4% | $66.77M+4.0% | |
| Nutritional Specialties | $46.81M+8.0% | $50.23M+9.4% | $48.15M+12.9% | $47.38M+10.6% | $43.35M+7.9% | |
| Performance Products | $18.9M-16.6% | $14.99M-9.7% | $17.45M-7.4% | $22.07M+12.7% | $22.67M+28.4% | |
| Vaccines | $38.63M+15.7% | $37.64M+13.5% | $40.11M+25.2% | $38.57M+20.6% | $33.38M+1.4% | |
| Revenue by Geography | ||||||
| Asia Pacific | $30.69M+8.7% | $19.77M+1.1% | $29.38M+101% | $35.03M+107% | $28.22M+65.2% | |
| EMEA | $44.47M+14.3% | $44.78M+37.4% | $44.94M+44.4% | $57.61M+77.8% | $38.91M+17.3% | |
| Latin America And Canada | $75.62M+6.9% | $87.6M+20.5% | $87.23M+22.6% | $84.07M+19.8% | $70.75M+31.9% | |
| US | $232.77M+10.9% | $221.76M+20.2% | $202.35M+41.0% | $201.99M+31.4% | $209.94M+31.8% | |
| Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization by Geography | ||||||
| BR | $38.79M— | $35.24M— | $35.39M— | $34.5M+6.9% | —— | |
| IE | $28.55M— | $27.43M— | $25.4M— | $25.14M+31.9% | —— | |
| IL | $84.53M— | $73.25M— | $74.07M— | $74.4M-4.9% | —— | |
| US | $234.5M— | $236.89M— | $238.01M— | $239.87M+133% | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Phibro Animal Health break its business down?
- Phibro Animal Health (PAHC) reports revenue by business across 3 parts — Animal Health, Mineral Nutrition and Performance Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Phibro Animal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Phibro Animal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
